GSK3B and prostate carcinoma: Also, inhibition of GSK-3β activity resulted in a strong decrease in cellular migration of all tested prostate cancer cell lines; PC-3 (92% inhibition), PC-3M-Pro4luc2 (-88%), C4-2B4 (-87%) and DU-145 (-71%) (Fig. 2c).